glp-1 adherence therapies and mortality risk: Implications for life insurers How pharmacists can support GLP-1

People who take semaglutide (the active ingredient in Ozempic and Wegovy) or tirzepatide (Mounjaro) frequently report: Nausea Vomiting Constipation or diarrhea Fatigue Headaches Decreased appetite These side effects can be uncomfortable, but theyre generally short-term and manageable for most patients

A semaglutide drug from the same manufacturer, Novo Nordisk, Wegovy is FDA-approved for weight management, while Ozempic isnt

Pain Reduction The peptide exhibits analgesic properties, reducing pain in damaged areas, which is valuable for managing muscle sprains and tears

doi: 10.1016/j.bpj.2015.07.051

Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels

In many cases, the term microdosing is used loosely and may refer to unsupervised or nonstandard dosing practices rather than medically guided titration